Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
04.12.24 | Spritzer Bhd: Spritzer Clinches 10th Consecutive "Brand of the Year" Award at the World Branding Awards in London | 339 | JCN Newswire | The decade milestone achievement reinforces Spritzer's deep resonance with its customers, unwavering dedication to excellence in product qualityLONDON, Dec 3, 2024 - (ACN Newswire) - Spritzer has once... ► Artikel lesen | |
04.12.24 | Naoris Protocol announces World's First Post-Quantum DePIN for Cybersecurity & Digital Trust ahead of Testnet | 517 | JCN Newswire | Delaware, USA, Dec 4, 2024 - (ACN Newswire) - As the digital world is increasingly threatened by advanced cyberattacks and looming quantum computing challenges,Naoris Protocol unveils groundbreaking... ► Artikel lesen | |
04.12.24 | HKTDC: 25th Hong Kong Forum concludes successfully | 441 | JCN Newswire | - More than 320 leaders from Hong Kong Business Association Worldwide join - to explore the latest development opportunities in Hong KongHONG KONG, Dec 4, 2024 - (ACN Newswire) - The 25th Hong Kong... ► Artikel lesen | |
04.12.24 | CITIC Telecom CPC's Internal and External Cybersecurity Excellence Honored with 3 Industry Awards | 409 | JCN Newswire | - Fosters Cybersecurity Culture Among Staff and Network Security as Top Priority- Strengthens Ecosystem Collaboration and Empowers Enterprises to Combat Security ThreatsHONG KONG, Dec 4, 2024 - (ACN... ► Artikel lesen | |
04.12.24 | Denso: DENSO Signs Memorandum of Understanding with Canatu of Finland for Practical Application of Carbon Nanotube Technology | 821 | JCN Newswire | KARIYA, JAPAN, Dec 4, 2024 - (JCN Newswire) - DENSO Corporation has recently signed a Memorandum of Understanding (MOU) with Canatu to advance the practical application of carbon nanotube technology.... ► Artikel lesen | |
04.12.24 | Everest Medicines Limited: Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy | 387 | JCN Newswire | SHANGHAI, Dec 4, 2024 - (ACN Newswire) - - Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) achieved... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
DEUTZ | 1.616 |
NVIDIA | 1.550 |
STEYR MOTORS | 1.502 |
TESLA | 1.444 |
RENK GROUP | 1.405 |
RHEINMETALL | 1.212 |
NEL | 1.057 |
TUI | 985 |
BYD | 949 |
NOVO NORDISK | 857 |
THYSSENKRUPP | 803 |
BAYER | 790 |
EVOTEC | 728 |
AIXTRON SE | 698 |
COMMERZBANK | 681 |
MUTARES | 587 |
SUSS MICROTEC | 587 |
PORSCHE AG | 585 |
DEUTSCHE BANK | 575 |
WOLFSPEED | 534 |
VOLKSWAGEN | 528 |
HENSOLDT | 511 |
MERCEDES-BENZ | 491 |
ALPHABET | 442 |
DEUTSCHE LUFTHANSA | 438 |